ACE and autosomal dominant polycystic kidney disease: It is not surprising that among the inactive compounds we found diuretics, ACE inhibitors, Angiotensin Receptor Blockers and Calcium channel blockers, which are indicated for the treatment of ADPKD-associated hypertension and are not expected to reduce cell proliferation.